NPR Health - Shots
JULY 24, 2022
The World Health Organization has declared monkeypox a public health emergency of global concern. From how it spreads to preventive measures, here's what you need to know about the disease.
STAT News
JULY 24, 2022
Anyone wondering whether Covid-19 vaccines are making a difference to this deadly and persistent pandemic can be in no doubt: they are. Millions of lives around the world have been saved thanks to the rollout of vaccines that were developed at record speed. Data from several global studies looking at “real world vaccine effectiveness” — which reflects what is really going on as the world continues to battle SARS-CoV-2 — show that in the first year of the vaccination p
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NPR Health - Shots
JULY 24, 2022
After finding she had ten bereaved kids in her class, one Florida teacher created a teen grief group. It's a place where kids can support each other and feel they're not alone.
Drug Patent Watch
JULY 24, 2022
Annual Drug Patent Expirations for ZETIA Zetia is a drug marketed by Organon and is included in one NDA. There are two patents protecting this drug and one Paragraph IV…. The post New patent expiration for Organon drug ZETIA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
NPR Health - Shots
JULY 24, 2022
Blood plasma donation centers along the U.S.-Mexico border have seen a sharp decline in donors after immigration regulations changed. Ayesha Rascoe talks with reporter Stefanie Dodt.
Drug Patent Watch
JULY 24, 2022
Annual Drug Patent Expirations for VELCADE Velcade is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are two…. The post New patent expiration for Takeda Pharms drug VELCADE appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
JULY 24, 2022
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent expiration for Alexza Pharms drug ADASUVE appeared first on DrugPatentWatch - Make Better Decisions.
FDA Law Blog
JULY 24, 2022
By Sara W. Koblitz — The Orange Book’s Therapeutic Equivalence Codes (TE Codes) play a critical role in our drug distribution and payment system. All states have “automatic substitution” laws that require prescriptions to be filled using a generic where available (unless otherwise ordered by the physician), and those substitutions are based on the TE Codes that FDA assigns to ANDAs, and where appropriate, 505(b)(2) NDAs.
Drug Patent Watch
JULY 24, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Slovakia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Slovakia? appeared first on DrugPatentWatch - Make Better Decisions.
NPR Health - Shots
JULY 24, 2022
Ayesha Rascoe talks with White House COVID-19 Response Coordinator Dr. Ashish Jha about President Biden testing positive and the state of the pandemic.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Expert insights. Personalized for you.
145 
Let's personalize your content